Abstract:ADVERTISEMENT RETURN TO ISSUEPREVAddition/CorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse AgonistLei ChenLei ChenDepartment of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering and Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, ChinaMore by Lei Chen, Mei SuMei SuJiangsu Carefree Pharmaceutical Co., Ltd. Nanjing 210042, ChinaMore by Mei Su, Wei WangWei WangJiangsu Carefree Pharmaceutical Co., Ltd. Nanjing 210042, ChinaMore by Wei Wang, Chun-Gu WangChun-Gu WangDepartment of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering and Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, ChinaMore by Chun-Gu Wang, Israa AssaniIsraa AssaniDepartment of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering and Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, ChinaMore by Israa Assani, Mu-Xuan WangMu-Xuan WangDepartment of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering and Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, ChinaMore by Mu-Xuan Wang, Shi-Feng ZhaoShi-Feng ZhaoDepartment of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering and Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, ChinaMore by Shi-Feng Zhao, Shen-Min LvShen-Min LvDepartment of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering and Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, ChinaMore by Shen-Min Lv, Jia-Wei WangJia-Wei WangDepartment of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering and Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, ChinaMore by Jia-Wei Wang, Bo SunBo SunDepartment of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering and Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, ChinaMore by Bo Sun, Yan LiYan LiDepartment of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering and Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, ChinaMore by Yan Li, Qiu Jin*Qiu JinJiangsu Carefree Pharmaceutical Co., Ltd. Nanjing 210042, China*Email: [email protected]More by Qiu Jin, and Zhi-Xin Liao*Zhi-Xin LiaoDepartment of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering and Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China*Email: [email protected]More by Zhi-Xin Liaohttps://orcid.org/0000-0001-6569-366XCite this: J. Med. Chem. 2021, 64, 24, 18235Publication Date (Web):December 4, 2021Publication History Published online4 December 2021Published inissue 23 December 2021https://doi.org/10.1021/acs.jmedchem.1c01926Copyright © 2021 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views1050Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (455 KB) Get e-Alerts Get e-Alerts

Correction to Synthesis and Biological Evaluation of 5-Benzylidenepyrimidine-2,4,6(1h,3h,5h)-trione Derivatives for the Treatment of Obesity-Related Nonalcoholic Fatty Liver Disease

Correction to Synthetic Approaches to the New Drugs Approved During 2015

Correction to “Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment”

Correction to Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist.

Correction to Evaluation and Discovery of Novel Synthetic Chalcone Derivatives As Anti-Inflammatory Agents

Guidelines for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Diseases

Correction to Acenaphtho[1,2-b]pyrrole-Based Selective Fibroblast Growth Factor Receptors 1 (FGFR1) Inhibitors: Design, Synthesis, and Biological Activity

Correction to Metabolomic and Genomic Evidence for Compromised Bile Acid Homeostasis by Senecionine, a Hepatotoxic Pyrrolizidine Alkaloid

Corrections to Discovery of (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione, a Readily Available and Orally Active Glitazone for the Treatment of Concanavalin A-Induced Acute Liver Injury of BALB/c Mice

Synthesis and biological evaluation of 3-methyl-5-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione derivatives for the treatment of diet-induced obesity.

Correction to Oleanane-Type Triterpenoids from the Leaves and Twigs of Fatsia Polycarpa

Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease

Correction to Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection

Correction to “BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo”

Correction to Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma

Corrrection to Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Novel Antitubercular Agents

Correction to Bioactive Indole Alkaloids and Phenyl Ether Derivatives from a Marine-Derived Aspergillus Sp. Fungus

ChemInform Abstract: Synthesis and Evaluation of 5‐Benzylidenethiazolidine‐2,4‐dione Derivatives for the Treatment of Nonalcoholic Fatty Liver Disease.

Correction to Design, Synthesis, and Antitumor Evaluation of Novel Histone Deacetylase Inhibitors Equipped with a Phenylsulfonylfuroxan Module as a Nitric Oxide Donor.

Correction to “Simplified Derivatives of Tetrandrine as Potent and Specific P-gp Inhibitors to Reverse Multidrug Resistance in Cancer Chemotherapy”